Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neuronetics Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
STIM
Nasdaq
3845
https://neurostar.com/neuronetics/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neuronetics Inc
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
- Apr 23rd, 2024 8:30 pm
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
- Apr 10th, 2024 12:31 pm
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
- Apr 1st, 2024 2:52 pm
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 27th, 2024 8:30 pm
Neuronetics wins FDA clearance for device to treat adolescents with depression
- Mar 27th, 2024 5:10 am
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
- Mar 25th, 2024 12:30 pm
Neuronetics (STIM) Progresses in MRD and TRD With New Deal
- Mar 8th, 2024 1:06 pm
Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023
- Mar 7th, 2024 7:00 pm
Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 3:16 pm
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
- Mar 7th, 2024 1:22 pm
Neuronetics Full Year 2023 Earnings: US$1.05 loss per share (vs US$1.38 loss in FY 2022)
- Mar 6th, 2024 10:18 am
Q4 2023 Neuronetics Inc Earnings Call
- Mar 6th, 2024 4:39 am
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates
- Mar 5th, 2024 1:40 pm
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
- Mar 5th, 2024 12:30 pm
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
- Feb 20th, 2024 1:30 pm
Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates
- Feb 15th, 2024 10:35 pm
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
- Feb 12th, 2024 1:32 pm
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
- Feb 6th, 2024 1:28 pm
After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain
- Jan 23rd, 2024 10:15 am
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
- Jan 8th, 2024 1:30 pm
Scroll